Cuál es el precio por TFF Pharmaceuticals, Inc. (TFFP)

Precio por TFF Pharmaceuticals, Inc. (TFFP) es de$0.065

Cuál es la capitalización de mercado por TFF Pharmaceuticals, Inc. (TFFP)

Capitalización de mercado por TFF Pharmaceuticals, Inc. (TFFP) es $94.10K

TFF Pharmaceuticals, Inc. (TFFP) Ratio P/E

Operating as a clinical-stage biopharmaceutical company, TFF Pharmaceuticals, Inc., leverages its proprietary Thin Film Freezing (TFF) technology platform for the advancement and commercialization of therapeutic products across the United States and Australia. A primary emphasis is placed on creating inhaled dry powder formulations to address various pulmonary ailments and disorders. Its two leading drug candidates, both currently in Phase II clinical trials, include TFF Voriconazole Inhalation Powder, designed to combat invasive pulmonary aspergillosis, and TFF Tacrolimus Inhalation Powder, aimed at preventing lung transplant rejection. Beyond these, the company's pipeline features other dry powder products like a cannabidiol substance targeting various epilepsy syndromes, anxiety, insomnia, and pain; an Inhaled SARS-CoV2 Monoclonal Antibody for COVID-19 patients; Niclosamide Inhalation Powder, intended for human tapeworm infections and COVID-19; and a range of other vaccines. Strategic partnerships are also central to its operations, including a licensing arrangement with the University of Texas at Austin for inhaled dry powder drug development, a joint development pact with Augmenta Bioworks, Inc. for the inhaled SARS-CoV2 monoclonal antibody, and a broad licensing and collaboration agreement with UNION therapeutics A/S. Established in 2018, the company maintains its headquarters in Austin, Texas.

Año	Ratio P/E	Cambiar
Not enough data for the provided dates.

Año

Ratio P/E

Cambiar

Not enough data for the provided dates.

Empresa	P/E Ratio	Diferencia del P/E Ratio	País
Vertex Pharmaceuticals Incorporated VRTX.US	28.05	-	US
Argenx SE ARGX.US	31.14	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	19.30	-	BE

Empresa

P/E Ratio

Diferencia del P/E Ratio

País